TERT-BUTYL 2,6-DIAZASPIRO[3.4]OCTANE-6-CARBOXYLATE HCL, 95.0%, 500mg

6-methyl-2-(4-methylphenyl)-2,6-dihydro-1,3,6,2-dioxazaborocine-4,8-diol, 95%, 25g

L-(-)-Talose>98.0%(HPLC)100mg

5-isopropyl-1,3,4-oxadiazol-2-amine, 95.0%, 10g

(S)-2-Methyl-1-(pyridin-2-yl)propan-1-amine dihydrochloride, 97%, 500mg

2-Amino-3-ethoxypyridine, 97.0%, 5g

Trimethylsulfoxonium Chloride>98.0%(T)5g

N,N-Dibenzylethenesulfonamide, 95%, 250mg

Conexión de junta esférica, 51, 150 mm, 1 pieza

Piperidina, mínimo 99%, para síntesis, 2,5 L, envase de vidrio

2-(4-Bromo-3-nitrophenyl)acetic acid, 98%, 1g

4-Bromopicolinic acid, 97.0%, 10g

tert-Butyl 3,6-diazabicyclo[3.1.1]heptane-6-carboxylate hydrochloride, 97%, 1g